{"id":71318,"date":"2025-09-18T10:03:50","date_gmt":"2025-09-18T10:03:50","guid":{"rendered":"https:\/\/kanboapp.com\/industries\/pharmaceutical\/enhancing-risk-visibility-in-pharmaceutical-qa-navigating-challenges-and-unlocking-opportunities-in-change-and-capa-management\/"},"modified":"2025-09-18T10:03:50","modified_gmt":"2025-09-18T10:03:50","slug":"enhancing-risk-visibility-in-pharmaceutical-qa-navigating-challenges-and-unlocking-opportunities-in-change-and-capa-management","status":"publish","type":"page","link":"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/enhancing-risk-visibility-in-pharmaceutical-qa-navigating-challenges-and-unlocking-opportunities-in-change-and-capa-management\/","title":{"rendered":"Enhancing Risk Visibility in Pharmaceutical QA: Navigating Challenges and Unlocking Opportunities in Change and CAPA Management"},"content":{"rendered":"<style> @media(min-width:1728px) { .tytulek{font-size:34px!important;max-width: 1200px!important;} .sekcja-tekst { margin-left: 40px!important; margin-right: 40px!important;} .artykul{margin-bottom:120px!important; margin-top:120px!important;} .menu-lewe a:hover { background:#E9F4FE!important; font-weight:600!important; font-size:16px!important; cursor:pointer!important; } .menu-lewe a { background:#FAFAFA; padding:8px 8px; border-radius: 8px; display: inline-block; outline: none; color:#0C3658!important; font-weight:600!important; font-size:16px!important; line-height: 150% !important;} .menu-lewe{margin-bottom: 8px!important;} .kolumna-tekst{    flex-basis:35%!important;} .compact-nag{display:none!important; } .naglowek-duzy {margin-bottom:24px!important; margin-top: 48px!important; font-size:25px!important; font-style:normal; font-weight:600!important; letter-spacing:-0.25px!important; line-height:1.2!important;} .naglowek-maly {margin-bottom:20px!important; font-size:19px!important; font-style:normal; font-weight:700!important; letter-spacing:-0.02em!important; line-height:1.2!important;} .naglowek-start {margin-bottom:40px!important; margin-top: 0px!important; font-size:25px!important; font-style:normal; font-weight:600!important; letter-spacing:-0.02em!important; line-height:1.2!important;}  .tekst-para {font-size:17px!important;line-height:160%!important;margin-bottom:24px!important;} .tekst-para-maly {font-size:14px!important;line-height:160%!important;margin-bottom:24px!important;} .prawy-tytul{font-size:16px!important;} .prawy-tekst {font-size:14px!important;} .prawy-link a{font-size:16px!important;} .spis { display:block!important; } .spis2 { display:block!important; } .pasek-lewy { margin-left:7%!important; } .pasek-prawy {  margin-right:7%!important; } } @media(min-width: 1440px) and (max-width:1727px) { .tytulek{font-size:34px!important;max-width: 1200px!important;} .sekcja-tekst { margin-left: 40px!important; margin-right: 40px!important;} .artykul{margin-bottom:120px!important; margin-top:120px!important;} .menu-lewe a:hover { background:#E9F4FE!important; font-weight:600!important; font-size:16px!important; cursor:pointer!important; } .menu-lewe a { background:#FAFAFA; padding:8px 8px; border-radius: 8px; display: inline-block; outline: none; color:#0C3658!important; font-weight:600!important; font-size:16px!important; line-height: 150% !important;} .menu-lewe{margin-bottom: 8px!important;} .kolumna-tekst{flex-basis:35%!important;} .compact-nag{display:none!important; } .naglowek-duzy {margin-bottom:24px!important; margin-top: 48px!important; font-size:25px!important; font-style:normal; font-weight:600!important; letter-spacing:-0.25px!important; line-height:1.2!important;} .naglowek-maly {margin-bottom:20px!important; font-size:19px!important; font-style:normal; font-weight:700!important; letter-spacing:-0.02em!important; line-height:1.2!important;} .naglowek-start {margin-bottom:40px!important; margin-top: 0px!important; font-size:25px!important; font-style:normal; font-weight:600!important; letter-spacing:-0.02em!important; line-height:1.2!important;} .tekst-para {font-size:17px!important;line-height:160%!important;margin-bottom:24px!important;} .tekst-para-maly {font-size:14px!important;line-height:160%!important;margin-bottom:24px!important;} .prawy-tytul{font-size:16px!important;} .prawy-tekst {font-size:14px!important;} .prawy-link a{font-size:16px!important;} .spis { display:block!important; } .spis2 { display:block!important; } .pasek-lewy {  margin-left:7%!important; } .pasek-prawy {  margin-right:7%!important; } } @media (min-width: 1024px) and (max-width:1439px) { .tytulek{font-size:34px!important;max-width: 1200px!important;} .sekcja-tekst { margin-left: 40px!important; margin-right: 40px!important;} .artykul{margin-bottom:120px!important; margin-top:120px!important;} .menu-lewe a:hover { background:#E9F4FE!important; font-weight:600!important; font-size:16px!important; cursor:pointer!important; } .menu-lewe a { background:#FAFAFA; padding:8px 8px; border-radius: 8px; display: inline-block; outline: none; color:#0C3658!important; font-weight:600!important; font-size:16px!important; line-height: 150% !important;} .menu-lewe{margin-bottom: 8px!important;} .kolumna-tekst{flex-basis:35%!important;} .compact-nag{display:none!important; } .naglowek-duzy {margin-bottom:24px!important; margin-top: 32px!important; font-size:25px!important; font-style:normal; font-weight:600!important; letter-spacing:-0.25px!important; line-height:1.2!important;} .naglowek-maly {margin-bottom:20px!important; font-size:19px!important; font-style:normal; font-weight:700!important; letter-spacing:-0.02em!important; line-height:1.2!important;} .naglowek-start {margin-bottom:40px!important; margin-top: 0px!important; font-size:25px!important; font-style:normal; font-weight:600!important; letter-spacing:-0.02em!important; line-height:1.2!important;} .tekst-para {font-size:17px!important;line-height:160%!important;margin-bottom:24px!important;} .tekst-para-maly {font-size:14px!important;line-height:160%!important;margin-bottom:24px!important;} .prawy-tytul{font-size:16px!important;} .prawy-tekst {font-size:14px!important;} .prawy-link a{font-size:16px!important;} .spis { display:block!important; } .spis2{ display:block!important; } .pasek-lewy {  margin-left:7%!important; } .pasek-prawy {  margin-right:7%!important; } } @media (min-width: 782px) and (max-width:1023px) { .tytulek{font-size:25px!important;max-width: 1200px!important;} .sekcja-tekst { margin-left: 40px!important; margin-right: 40px!important;}  .artykul{margin-bottom:80px!important; margin-top:30px!important;} .menu-lewe a:hover { background:#E9F4FE!important; font-weight:600!important; font-size:14px!important; cursor:pointer!important; } .menu-lewe a { background:#FAFAFA; padding:10px 4px; border-radius: 8px; display: inline-block; outline: none; color:#0C3658!important; font-weight:600!important; font-size:14px!important; line-height: 150% !important;}  .menu-lewe{margin-bottom: 8px!important;} .kolumna-tekst{flex-basis:60%!important;} .compact-nag{display:block!important; } .naglowek-duzy {margin-bottom:24px!important; margin-top: 32px!important; font-size:19px!important; font-style:normal; font-weight:600!important; letter-spacing:-0.19px!important; line-height:1.2!important;} .naglowek-maly {margin-bottom:20px!important; font-size:16px!important; font-style:normal; font-weight:700!important; letter-spacing:-0.02em!important; line-height:1.2!important;} .naglowek-start {margin-bottom:40px!important; margin-top: 32px!important; font-size:25px!important; font-style:normal; font-weight:600!important; letter-spacing:-0.02em!important; line-height:1.2!important;} .tekst-para {font-size:14px!important;line-height:160%!important;margin-bottom:24px!important;} .tekst-para-maly {font-size:12px!important;line-height:160%!important;margin-bottom:24px!important;} .prawy-tytul{font-size:16px!important;} .prawy-tekst {font-size:13px!important;} .prawy-link a{font-size:16px!important;} .spis { display:block!important; } .spis2 { display:none!important; } .pasek-lewy { margin-left:32px!important; } .pasek-prawy {margin-right:32px!important; } } @media (max-width:781px) {  .tytulek{font-size:25px!important;max-width: 1200px!important;} .sekcja-tekst { margin-left: 16px!important; margin-right: 16px!important;}  .artykul{margin-bottom:80px!important; margin-top:30px!important;} .menu-lewe a:hover { background:#E9F4FE!important; font-weight:600!important; font-size:14px!important; cursor:pointer!important; } .menu-lewe a { background:#FAFAFA; padding:10px 4px; border-radius: 8px; display: inline-block; outline: none; color:#0C3658!important; font-weight:600!important; font-size:14px!important; line-height: 150% !important;} .menu-lewe{margin-bottom: 8px!important;} .kolumna-tekst{flex-basis:100%!important;} .compact-nag{display:block!important; } .naglowek-duzy {margin-bottom:24px!important; margin-top: 48px!important; font-size:19px!important; font-style:normal; font-weight:600!important; letter-spacing:-0.19px!important; line-height:1.2!important;} .naglowek-maly {margin-bottom:20px!important; font-size:16px!important; font-style:normal; font-weight:700!important; letter-spacing:-0.02em!important; line-height:1.2!important;} .naglowek-start {margin-bottom:40px!important; margin-top: 32px!important; font-size:25px!important; font-style:normal; font-weight:600!important; letter-spacing:-0.02em!important; line-height:1.2!important;} .tekst-para {font-size:14px!important;line-height:160%!important;margin-bottom:24px!important;} .tekst-para-maly {font-size:12px!important;line-height:160%!important;margin-bottom:24px!important;} .prawy-tytul{font-size:16px!important;} .prawy-tekst {font-size:13px!important;} .prawy-link a{font-size:16px!important;} .spis { display:none!important; } .spis2 { display:none!important; } .pasek-lewy { margin-left:16px!important; } .pasek-prawy {margin-right:16px!important; } } .prawy-link a:hover { color:#145A92!important} .banner { margin-top:80px; margin-bottom:80px; } .jazda-nowsza { position:sticky!important; top: 120px; overflow: auto; max-height: 85vh; }  .fobrazek { margin-bottom: -40px!important; } .sekcja5-przycisk a:hover { background: linear-gradient(0deg, rgba(0, 0, 0, 0.15), rgba(0, 0, 0, 0.15)), #ED4B9E!important; }  .sekcja5-przycisk a:focus { background: linear-gradient(0deg, rgba(0, 0, 0, 0.15), rgba(0, 0, 0, 0.15)), #ED4B9E!important; } .vlp-layout-blogs .vlp-block-0 {font-weight: 600!important; } .prawy-tytul-pulpit {font-size:19px!important;} .ct-container-narrow {max-width: 1200px!important;}  :nth-last-child(1 of .tekst-para) {margin-bottom: 0px!important;} <\/style><script> function lewemenu(zm) { var elements = document.getElementsByClassName(\"menu-lewe\"); var i,link1,link2; for (i = 0; i < elements.length; i++) {    link1 = elements[i].getElementsByTagName(\"a\");     link1[0].style.fontWeight = \"600\";     link1[0].style.backgroundColor= \"#FAFAFA\"; } link2 = elements[zm].getElementsByTagName(\"a\"); link2[0].style.fontWeight = \"600\"; link2[0].style.backgroundColor= \"#E9F4FE\"; } <\/script><div class=\"wp-block-getwid-section alignfull alignfull getwid-margin-top-none getwid-margin-bottom-none getwid-section-content-full-width\"><div class=\"wp-block-getwid-section__wrapper getwid-padding-top-none getwid-padding-bottom-none getwid-padding-left-none getwid-padding-right-none getwid-margin-left-none getwid-margin-right-none\" style=\"min-height:100vh\"><div class=\"wp-block-getwid-section__inner-wrapper\"><div class=\"wp-block-getwid-section__background-holder\"><div class=\"wp-block-getwid-section__background has-background\" style=\"background-color:#fafafa\"><\/div><div class=\"wp-block-getwid-section__foreground\"><\/div><\/div><div class=\"wp-block-getwid-section__content\"><div class=\"wp-block-getwid-section__inner-content\"><div class=\"wp-block-columns alignfull artykul is-layout-flex wp-container-core-columns-is-layout-f96e3eba wp-block-columns-is-layout-flex\" style=\"margin-top:0px;margin-bottom:0px\"><div class=\"wp-block-column pasek-lewy spis jazda-nowsza is-layout-flow wp-block-column-is-layout-flow\"><div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-995f960e wp-block-columns-is-layout-flex\"><div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\"><p class=\"menu-lewe wp-elements-fdc6b5d33599b2a988ce937ed0bc5d06 wp-block-paragraph\" onclick=\"lewemenu(0)\"><a href=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/enhancing-risk-visibility-in-pharmaceutical-qa-navigating-challenges-and-unlocking-opportunities-in-change-and-capa-management\/#section1\" data-type=\"URL\" data-id=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/enhancing-risk-visibility-in-pharmaceutical-qa-navigating-challenges-and-unlocking-opportunities-in-change-and-capa-management\/#section1\"  style=\"font-size:clamp(14px, 0.875rem + ((1vw - 3.2px) * 0.391), 19px);font-style:normal;font-weight:600;line-height:1.2;color:#0c3658\">Why change?<\/a><\/p><p class=\"menu-lewe wp-elements-c44434d58439a43b020b47636e8103d1 wp-block-paragraph\" onclick=\"lewemenu(1)\"><a href=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/enhancing-risk-visibility-in-pharmaceutical-qa-navigating-challenges-and-unlocking-opportunities-in-change-and-capa-management\/#section2\" data-type=\"URL\" data-id=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/enhancing-risk-visibility-in-pharmaceutical-qa-navigating-challenges-and-unlocking-opportunities-in-change-and-capa-management\/#section2\"  style=\"font-size:clamp(14px, 0.875rem + ((1vw - 3.2px) * 0.391), 19px);font-style:normal;font-weight:600;line-height:1.2;color:#0c3658\">Background \/ Definition<\/a><\/p><p class=\"menu-lewe wp-elements-c41f23e66cafa29416ab4f9f356bbcd5 wp-block-paragraph\" onclick=\"lewemenu(2)\"><a href=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/enhancing-risk-visibility-in-pharmaceutical-qa-navigating-challenges-and-unlocking-opportunities-in-change-and-capa-management\/#section3\" data-type=\"URL\" data-id=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/enhancing-risk-visibility-in-pharmaceutical-qa-navigating-challenges-and-unlocking-opportunities-in-change-and-capa-management\/#section3\"  style=\"font-size:clamp(14px, 0.875rem + ((1vw - 3.2px) * 0.391), 19px);font-style:normal;font-weight:600;line-height:1.2;color:#0c3658\">Case-Style Mini-Examples<\/a><\/p><p class=\"menu-lewe wp-elements-c0d7c30f4072b9588613727e81a8cd8a wp-block-paragraph\" onclick=\"lewemenu(3)\"><a href=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/enhancing-risk-visibility-in-pharmaceutical-qa-navigating-challenges-and-unlocking-opportunities-in-change-and-capa-management\/#section4\" data-type=\"URL\" data-id=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/enhancing-risk-visibility-in-pharmaceutical-qa-navigating-challenges-and-unlocking-opportunities-in-change-and-capa-management\/#section4\"  style=\"font-size:clamp(14px, 0.875rem + ((1vw - 3.2px) * 0.391), 19px);font-style:normal;font-weight:600;line-height:1.2;color:#0c3658\">What will change?<\/a><\/p><p class=\"menu-lewe wp-elements-9fbd576a25af97822ed9efe732618c3e wp-block-paragraph\" onclick=\"lewemenu(4)\"><a href=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/enhancing-risk-visibility-in-pharmaceutical-qa-navigating-challenges-and-unlocking-opportunities-in-change-and-capa-management\/#section5\" data-type=\"URL\" data-id=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/enhancing-risk-visibility-in-pharmaceutical-qa-navigating-challenges-and-unlocking-opportunities-in-change-and-capa-management\/#section5\"  style=\"font-size:clamp(14px, 0.875rem + ((1vw - 3.2px) * 0.391), 19px);font-style:normal;font-weight:600;line-height:1.2;color:#0c3658\">What will not change?<\/a><\/p><p class=\"menu-lewe wp-elements-876b474e5473efbf607a9fa9bf09a2fa wp-block-paragraph\" onclick=\"lewemenu(5)\"><a href=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/enhancing-risk-visibility-in-pharmaceutical-qa-navigating-challenges-and-unlocking-opportunities-in-change-and-capa-management\/#section6\" data-type=\"URL\" data-id=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/enhancing-risk-visibility-in-pharmaceutical-qa-navigating-challenges-and-unlocking-opportunities-in-change-and-capa-management\/#section6\"  style=\"font-size:clamp(14px, 0.875rem + ((1vw - 3.2px) * 0.391), 19px);font-style:normal;font-weight:600;line-height:1.2;color:#0c3658\">Key management questions (Q\/A)<\/a><\/p><p class=\"menu-lewe wp-elements-84bc0ea25dd80d4ff52b91731a6149e8 wp-block-paragraph\" onclick=\"lewemenu(6)\"><a href=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/enhancing-risk-visibility-in-pharmaceutical-qa-navigating-challenges-and-unlocking-opportunities-in-change-and-capa-management\/#section7\" data-type=\"URL\" data-id=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/enhancing-risk-visibility-in-pharmaceutical-qa-navigating-challenges-and-unlocking-opportunities-in-change-and-capa-management\/#section7\"  style=\"font-size:clamp(14px, 0.875rem + ((1vw - 3.2px) * 0.391), 19px);font-style:normal;font-weight:600;line-height:1.2;color:#0c3658\">Atomic Facts<\/a><\/p><p class=\"menu-lewe wp-elements-f04eeefa97a56ccd89e9bc3bcb2df017 wp-block-paragraph\" onclick=\"lewemenu(7)\"><a href=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/enhancing-risk-visibility-in-pharmaceutical-qa-navigating-challenges-and-unlocking-opportunities-in-change-and-capa-management\/#section8\" data-type=\"URL\" data-id=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/enhancing-risk-visibility-in-pharmaceutical-qa-navigating-challenges-and-unlocking-opportunities-in-change-and-capa-management\/#section8\"  style=\"font-size:clamp(14px, 0.875rem + ((1vw - 3.2px) * 0.391), 19px);font-style:normal;font-weight:600;line-height:1.2;color:#0c3658\">Mini-FAQ<\/a><\/p><p class=\"menu-lewe wp-elements-6c933ca71484cd47a96852ba71f11d7d wp-block-paragraph\" onclick=\"lewemenu(8)\"><a href=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/enhancing-risk-visibility-in-pharmaceutical-qa-navigating-challenges-and-unlocking-opportunities-in-change-and-capa-management\/#section9\" data-type=\"URL\" data-id=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/enhancing-risk-visibility-in-pharmaceutical-qa-navigating-challenges-and-unlocking-opportunities-in-change-and-capa-management\/#section9\"  style=\"font-size:clamp(14px, 0.875rem + ((1vw - 3.2px) * 0.391), 19px);font-style:normal;font-weight:600;line-height:1.2;color:#0c3658\">Data Table<\/a><\/p><p class=\"menu-lewe wp-elements-207eb7bd7a8533b47a9044371b9b6efd wp-block-paragraph\" onclick=\"lewemenu(9)\"><a href=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/enhancing-risk-visibility-in-pharmaceutical-qa-navigating-challenges-and-unlocking-opportunities-in-change-and-capa-management\/#section10\" data-type=\"URL\" data-id=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/enhancing-risk-visibility-in-pharmaceutical-qa-navigating-challenges-and-unlocking-opportunities-in-change-and-capa-management\/#section10\"  style=\"font-size:clamp(14px, 0.875rem + ((1vw - 3.2px) * 0.391), 19px);font-style:normal;font-weight:600;line-height:1.2;color:#0c3658\">Answer Capsule<\/a><\/p><p class=\"menu-lewe wp-elements-f810985dd4ac7d97596403fc47c0242e wp-block-paragraph\" onclick=\"lewemenu(10)\"><a href=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/enhancing-risk-visibility-in-pharmaceutical-qa-navigating-challenges-and-unlocking-opportunities-in-change-and-capa-management\/#section11\" data-type=\"URL\" data-id=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/enhancing-risk-visibility-in-pharmaceutical-qa-navigating-challenges-and-unlocking-opportunities-in-change-and-capa-management\/#section11\"  style=\"font-size:clamp(14px, 0.875rem + ((1vw - 3.2px) * 0.391), 19px);font-style:normal;font-weight:600;line-height:1.2;color:#0c3658\">Paragraph for AI Agents, Bots, and Scrapers (JSON Summary)<\/a><\/p><\/div><\/div><\/div><div class=\"wp-block-column kolumna-tekst is-layout-flow wp-block-column-is-layout-flow\"><div class=\"wp-block-getwid-section alignfull sekcja-tekst alignfull getwid-margin-top-none getwid-margin-bottom-none getwid-section-content-full-width\"><div class=\"wp-block-getwid-section__wrapper getwid-padding-top-none getwid-padding-bottom-none getwid-padding-left-none getwid-padding-right-none getwid-margin-left-none getwid-margin-right-none\" style=\"min-height:100vh\"><div class=\"wp-block-getwid-section__inner-wrapper\"><div class=\"wp-block-getwid-section__background-holder\"><div class=\"wp-block-getwid-section__background\"><\/div><div class=\"wp-block-getwid-section__foreground\"><\/div><\/div><div class=\"wp-block-getwid-section__content\"><div class=\"wp-block-getwid-section__inner-content\"><h1 class=\"wp-block-heading tytulek\" style=\"margin-bottom:40px;font-style:normal;font-weight:700;letter-spacing:-0.34px;line-height:1.2\">Enhancing Risk Visibility in Pharmaceutical QA: Navigating Challenges and Unlocking Opportunities in Change and CAPA Management<\/h1><h2 class=\"wp-block-heading naglowek-duzy\" id=\"section1\">Why change?<\/h2><p class=\"tekst-para wp-block-paragraph\">In the pharmaceutical industry, risk visibility is crucial due to the high stakes associated with drug development, manufacturing, compliance, and patient safety. The pressure to maintain clear sightlines of potential risks is amplified by various factors:<\/p><p class=\"tekst-para wp-block-paragraph\">1. Regulatory Compliance: Pharmaceuticals are heavily regulated. Companies must comply with stringent regulations set by bodies such as the FDA in the U.S. or the EMA in Europe. Any deviation or lack of transparency can lead to severe penalties, halted productions, or even bans on products.<\/p><p class=\"tekst-para wp-block-paragraph\">2. Patient Safety: Ensuring patient safety is paramount. An undetected or poorly managed risk in the drug development process can lead to adverse effects, patient harm, or fatalities, damaging a company\u2019s reputation and financial stability.<\/p><p class=\"tekst-para wp-block-paragraph\">3. Financial Implications: The cost of bringing a drug to market is astronomical, often exceeding $2 billion. Delays due to unmanaged risks can escalate costs or completely nullify financial investments.<\/p><p class=\"tekst-para wp-block-paragraph\">4. Competitive Pressures: The pharmaceutical industry is highly competitive. Companies must innovate swiftly while managing risks to maintain market edge. A lack of risk visibility can lead to missed opportunities or damage from competitor activities.<\/p><p class=\"tekst-para wp-block-paragraph\">5. Supply Chain Complexity: The global nature of modern supply chains means numerous stages and parties are involved in drug production. Without transparent risk management, disruptions can occur that impact timelines, costs, and product availability.<\/p><p class=\"tekst-para wp-block-paragraph\">6. Public Trust: The public\u2019s trust in pharmaceutical companies is fragile and easily impacted by scandals or product recalls. Visibility into potential risks is necessary to maintain and build public trust.<\/p><p class=\"tekst-para wp-block-paragraph\">Quantifying the risk of inaction involves assessing potential consequences:<\/p><p class=\"tekst-para wp-block-paragraph\">- Financial Loss: Inaction can lead to direct financial losses from fines, lawsuits, and recall costs. Indirectly, it impacts stock prices and market valuation.<\/p><p class=\"tekst-para wp-block-paragraph\">  <\/p><p class=\"tekst-para wp-block-paragraph\">- Delayed Time-to-Market: Risk mismanagement slows down the development process, delaying market entry and revenue generation.<\/p><p class=\"tekst-para wp-block-paragraph\">- Increased Costs: Unforeseen disruptions can inflate operational costs due to overtime, expedited shipping, and sourcing alternative materials or suppliers.<\/p><p class=\"tekst-para wp-block-paragraph\">- Reputation Damage: Trust recovery from a failed product or safety incident can take years, affecting long-term revenue and partnerships.<\/p><p class=\"tekst-para wp-block-paragraph\">- Non-Compliance Fines: Regulatory bodies impose hefty fines for non-compliance. For example, the FDA has levied fines ranging from tens to hundreds of millions of dollars against companies for various infractions.<\/p><p class=\"tekst-para wp-block-paragraph\">Effective risk visibility often involves robust systems or frameworks to capture, analyze, and address potential risks. While discussing software solutions, it\u2019s crucial to remain agnostic to specific products. However, tools like KanBo can serve as examples of how digital platforms facilitate risk management by organizing workflows, ensuring compliance, and keeping track of regulatory changes, thereby enhancing risk visibility throughout the pharma processes.<\/p><p class=\"tekst-para wp-block-paragraph\">In conclusion, the pressure to achieve robust risk visibility in pharmaceuticals is immense due to the intertwining of patient safety, regulatory compliance, financial implications, and competitive dynamics. Failing to manage these risks effectively can lead to severe repercussions, emphasizing the need for strategic investment in comprehensive risk management systems.<\/p><h3 class=\"wp-block-heading naglowek-duzy\" id=\"section2\">Background \/ Definition<\/h3><p class=\"tekst-para wp-block-paragraph\">Risk Visibility in Change & CAPA Management for Pharmaceutical Quality Assurance Managers<\/p><p class=\"tekst-para wp-block-paragraph\">In the pharmaceutical sector, ensuring high quality and compliance involves managing changes and Corrective and Preventive Actions (CAPA) effectively. Risk visibility is a key component, enabling Quality Assurance Managers to anticipate, identify, and mitigate risks associated with changes in processes, materials, or systems that could potentially impact product quality and patient safety.<\/p><p class=\"tekst-para wp-block-paragraph\">Key Terms:<\/p><p class=\"tekst-para wp-block-paragraph\">1. Risk Visibility: The ability to identify and understand potential risks at all stages of the process. In Change and CAPA management, it involves having clear insights into the status, impact, and interdependencies of different changes and actions.<\/p><p class=\"tekst-para wp-block-paragraph\">2. Change Management: The process of planning, implementing, and monitoring changes within the organization to improve outcomes and address issues without compromising quality.<\/p><p class=\"tekst-para wp-block-paragraph\">3. CAPA Management: A systematic approach to identifying, correcting, and preventing quality issues to ensure continuous improvement.<\/p><p class=\"tekst-para wp-block-paragraph\">KanBo enhances Risk Visibility in Change & CAPA Management using three core concepts:<\/p><p class=\"tekst-para wp-block-paragraph\">1. Visible Blockers:<\/p><p class=\"tekst-para wp-block-paragraph\">   - KanBo's Card Blockers help identify issues or obstacles causing delays. By categorizing these blockers as local, global, or on-demand, QA Managers can quickly diagnose the root cause of delays in change or CAPA processes. This transparency ensures prompt action and minimizes downtime.<\/p><p class=\"tekst-para wp-block-paragraph\">2. Mapped Dependencies:<\/p><p class=\"tekst-para wp-block-paragraph\">   - With Card Relations, KanBo allows larger tasks to be broken down into smaller, manageable pieces. These relations, whether parent-child or next-previous, map out dependencies clearly. This visualization is crucial for Quality Assurance Managers to understand the critical path and manage risks that arise from overlapping tasks or interconnected processes.<\/p><p class=\"tekst-para wp-block-paragraph\">3. Notifications:<\/p><p class=\"tekst-para wp-block-paragraph\">   - KanBo's Notifications keep everyone informed by delivering real-time updates on changes to the cards and spaces they are part of. When a change status is updated, comments are added, or files are attached, notifications serve as immediate alerts, ensuring that QA Managers and their teams remain informed and can take timely actions to address any new risks.<\/p><p class=\"tekst-para wp-block-paragraph\">By reframing risk visibility with these tools, KanBo creates an environment where Quality Assurance Managers can manage Change and CAPA processes with clarity and confidence, ultimately supporting compliance and ensuring high-quality outputs in the pharmaceutical industry. This approach not only enhances transparency but also facilitates proactive risk management, preventing potential issues before they impact the end product.<\/p><h3 class=\"wp-block-heading naglowek-duzy\" id=\"section3\">Case-Style Mini-Examples<\/h3><p class=\"tekst-para wp-block-paragraph\">Case Example: Overcoming Risk Visibility Challenges in Pharmaceutical QA Using KanBo<\/p><p class=\"tekst-para wp-block-paragraph\">Background:<\/p><p class=\"tekst-para wp-block-paragraph\">Emma, a Quality Assurance Manager at a leading pharmaceutical company, is responsible for managing Change and CAPA processes. Given the stringent regulatory landscape and the critical need to ensure patient safety, risk visibility within these processes is paramount. Emma's team faces significant challenges using traditional methods such as spreadsheets and email threads, which are cumbersome and error-prone, often leading to delays and missed connections.<\/p><p class=\"tekst-para wp-block-paragraph\">Challenges with Traditional Methods:<\/p><p class=\"tekst-para wp-block-paragraph\">1. Lack of Transparency and Delays: Traditional methods prevent Emma from having a clear, real-time view of where each change or CAPA task stands. Delays become apparent only after significant time has lapsed, leading to prolonged project timelines.<\/p><p class=\"tekst-para wp-block-paragraph\">2. Complex Dependency Management: With multiple interrelated tasks, manual tracking of dependencies often leads to oversight, resulting in task misalignment and potential risks being unnoticed until later stages.<\/p><p class=\"tekst-para wp-block-paragraph\">3. Ineffective Communication: Email-based communications about task updates and issues frequently get lost or are not acted upon swiftly, leading to miscommunication and missed mitigation opportunities.<\/p><p class=\"tekst-para wp-block-paragraph\">Implementation of KanBo:<\/p><p class=\"tekst-para wp-block-paragraph\">Adopting KanBo provided Emma and her team with a structured and transparent approach to manage Change and CAPA processes:<\/p><p class=\"tekst-para wp-block-paragraph\">1. Card Blockers for Transparent Risk Identification:<\/p><p class=\"tekst-para wp-block-paragraph\">   - KanBo's Card Blockers allow Emma to mark issues as local, global, or on-demand, ensuring clarity on what is holding tasks up. This visualization helps the team quickly address problems, reducing delays and ensuring continuous progress.<\/p><p class=\"tekst-para wp-block-paragraph\">2. Efficient Dependency Mapping with Card Relations:<\/p><p class=\"tekst-para wp-block-paragraph\">   - By using Card Relations, Emma can break larger tasks into smaller components, clearly mapping their dependencies. This visibility prevents scheduled conflicts and ensures that all team members understand the flow and sequence of tasks, reducing the risk of oversight.<\/p><p class=\"tekst-para wp-block-paragraph\">3. Instant Updates with Notifications:<\/p><p class=\"tekst-para wp-block-paragraph\">   - The Notifications feature provides real-time alerts about updates or changes within cards. Emma remains informed about progress, new comments, or file attachments, enabling her to take immediate corrective actions as necessary.<\/p><p class=\"tekst-para wp-block-paragraph\">Outcomes with KanBo:<\/p><p class=\"tekst-para wp-block-paragraph\">- Enhanced Risk Visibility: Emma can now quickly anticipate and mitigate potential risks, ensuring compliance and high quality in drug production.<\/p><p class=\"tekst-para wp-block-paragraph\">- Improved Efficiency: With clear mapping of task dependencies and blockers, the Change and CAPA processes are streamlined, reducing project completion time.<\/p><p class=\"tekst-para wp-block-paragraph\">- Better Communication and Collaboration: Real-time notifications and updates ensure that all team members are on the same page, facilitating prompt decision-making and fostering a proactive risk management culture.<\/p><p class=\"tekst-para wp-block-paragraph\">In conclusion, leveraging KanBo has transformed how Emma manages risk visibility within Change and CAPA processes. The improved transparency and communication align with her goal of maintaining high standards of quality assurance, ultimately contributing to the company's compliance and success in the pharmaceutical industry.<\/p><h3 class=\"wp-block-heading naglowek-duzy\" id=\"section4\">What will change?<\/h3><p class=\"tekst-para wp-block-paragraph\">Transitioning from Old School Tools to KanBo for Enhanced Risk Visibility in Change & CAPA Management<\/p><p class=\"tekst-para wp-block-paragraph\">In the pharmaceutical sector, traditional tools and outdated methods often fall short in ensuring effective risk visibility within Change & CAPA Management. The lack of real-time updates, limited accessibility, and poor visualization of relationships between tasks make it challenging for Quality Assurance Managers to anticipate and mitigate risks. KanBo addresses these challenges by offering modern, collaborative features that enhance transparency and facilitate proactive risk management.<\/p><p class=\"tekst-para wp-block-paragraph\">Old School Tools & Methods:<\/p><p class=\"tekst-para wp-block-paragraph\">- Paper-based Documentation: Changes and CAPA actions are documented manually, leading to delays in updates and high risk of miscommunication.<\/p><p class=\"tekst-para wp-block-paragraph\">- Spreadsheets: Relying on static spreadsheets for tracking changes, where risks cannot be updated or visualized dynamically.<\/p><p class=\"tekst-para wp-block-paragraph\">- Limited Communication Channels: Communication confined to emails or meetings, resulting in fragmented information flow and slow response times.<\/p><p class=\"tekst-para wp-block-paragraph\">KanBo's Key Enhancements for Risk Visibility:<\/p><p class=\"tekst-para wp-block-paragraph\">1. Visible Blockers:<\/p><p class=\"tekst-para wp-block-paragraph\">   - Traditional Challenge: Identifying bottlenecks requires time-consuming manual checks.<\/p><p class=\"tekst-para wp-block-paragraph\">   - KanBo Solution: Card Blockers provide instant identification and categorization of issues, ensuring immediate visibility and quicker resolution.<\/p><p class=\"tekst-para wp-block-paragraph\">2. Mapped Dependencies:<\/p><p class=\"tekst-para wp-block-paragraph\">   - Traditional Challenge: Lack of clarity on task dependencies leads to overlooked risks and mismanagement.<\/p><p class=\"tekst-para wp-block-paragraph\">   - KanBo Solution: Card Relations with parent-child and next-previous mappings make dependencies visible, aiding QA Managers in understanding the critical path and preventing risks related to task overlaps or missing dependencies.<\/p><p class=\"tekst-para wp-block-paragraph\">3. Notifications:<\/p><p class=\"tekst-para wp-block-paragraph\">   - Traditional Challenge: Changes and risks often go unnoticed due to infrequent updates and manual tracking.<\/p><p class=\"tekst-para wp-block-paragraph\">   - KanBo Solution: Real-time Notifications keep teams informed of status updates, comments, or file attachments, allowing QA Managers to quickly identify and address emerging risks.<\/p><p class=\"tekst-para wp-block-paragraph\">By integrating KanBo into the Change & CAPA Management processes, pharmaceutical Quality Assurance Managers can move away from outdated tools towards a digital platform that offers comprehensive risk visibility. This transition supports compliance, enhances decision-making, and ensures high-quality outputs consistently.<\/p><h3 class=\"wp-block-heading naglowek-duzy\" id=\"section5\">What will not change?<\/h3><p class=\"tekst-para wp-block-paragraph\">In the realm of Risk Visibility for Quality Assurance Managers in Change and CAPA Management within the pharmaceutical industry, certain elements remain constant despite technological advancements. Leadership judgment, strategy ownership, and accountability continue to rely fundamentally on human capabilities; technology serves to amplify these aspects rather than replace them. These constants underscore the importance of a human-first approach in embedding technology effectively to support decision-making processes and enhance visibility into potential risks, while ultimately ensuring quality and compliance are maintained.<\/p><h3 class=\"wp-block-heading naglowek-duzy\" id=\"section6\">Key management questions (Q\/A)<\/h3><p class=\"tekst-para wp-block-paragraph\">Who did what and when?  <\/p><p class=\"tekst-para wp-block-paragraph\">The QA Manager used KanBo's Card Blockers to track and address delays in change processes, ensuring visibility of who was responsible for each action and its timeline.<\/p><p class=\"tekst-para wp-block-paragraph\">What threatens the critical path?  <\/p><p class=\"tekst-para wp-block-paragraph\">Unforeseen dependencies between tasks, identified through KanBo's Mapped Dependencies, threaten the critical path by potentially causing delays in interconnected processes.<\/p><p class=\"tekst-para wp-block-paragraph\">Where are bottlenecks?  <\/p><p class=\"tekst-para wp-block-paragraph\">Bottlenecks occur when issues detected as Card Blockers remain unresolved, leading to delayed CAPA implementation or stalled changes.<\/p><p class=\"tekst-para wp-block-paragraph\">Which tasks are overdue and why?  <\/p><p class=\"tekst-para wp-block-paragraph\">Tasks are overdue due to unresolved blockers causing delays, or dependencies that were not mapped accurately, resulting in mismanaged task sequences.<\/p><h3 class=\"wp-block-heading naglowek-duzy\" id=\"section7\">Atomic Facts<\/h3><p class=\"tekst-para wp-block-paragraph\">1. Regulatory Compliance Importance: Pharmaceutical companies must adhere to strict guidelines from regulatory agencies like the FDA and EMA. Failure to ensure risk visibility and compliance can lead to production halts and significant financial penalties.<\/p><p class=\"tekst-para wp-block-paragraph\">2. Impact on Patient Safety: Inadequate risk visibility can result in undetected issues, potentially compromising patient safety, leading to serious adverse effects, legal challenges, and a tarnished reputation.<\/p><p class=\"tekst-para wp-block-paragraph\">3. Financial Stakes: The cost of bringing a drug to market averages over $2 billion. Effective risk visibility can prevent costly delays, help maintain project budgets, and protect financial investments.<\/p><p class=\"tekst-para wp-block-paragraph\">4. Supply Chain Risks: With complex, global supply chains, risk visibility is essential to managing potential disruptions that can affect timelines and product availability, maintaining seamless operations.<\/p><p class=\"tekst-para wp-block-paragraph\">5. Public Trust Dependency: Continuous and transparent risk management is vital for maintaining public trust, crucial for long-term reputation management and market success.<\/p><p class=\"tekst-para wp-block-paragraph\">6. Cost of Non-Compliance: Regulatory non-compliance can result in fines ranging from tens to hundreds of millions, highlighting the importance of continuous, transparent risk assessment and management systems.<\/p><p class=\"tekst-para wp-block-paragraph\">7. Change & CAPA Management: Quality Assurance Managers rely on clear insights into potential risks associated with changes (Change Management) and quality issues (CAPA Management) to safeguard product quality.<\/p><p class=\"tekst-para wp-block-paragraph\">8. Effective Tools for Risk Management: Platforms such as KanBo enhance risk visibility in pharmaceutical Change and CAPA management by offering features like visible blockers, mapped dependencies, and real-time notifications, ensuring that Quality Assurance Managers can proactively address and mitigate risks.<\/p><h3 class=\"wp-block-heading naglowek-duzy\" id=\"section8\">Mini-FAQ<\/h3><p class=\"tekst-para wp-block-paragraph\">1. What is risk visibility in Change & CAPA Management for pharmaceutical quality assurance?<\/p><p class=\"tekst-para wp-block-paragraph\">   - Risk visibility refers to the ability to identify and understand potential risks in Change & CAPA Management. It involves gaining insights into the status, impact, and interdependencies of changes and actions to ensure quality and compliance in pharmaceutical processes.<\/p><p class=\"tekst-para wp-block-paragraph\">2. Why is risk visibility important for Quality Assurance Managers in the pharmaceutical industry?<\/p><p class=\"tekst-para wp-block-paragraph\">   - Risk visibility is crucial because it helps anticipate, identify, and mitigate risks associated with changes that could impact product quality and patient safety. It supports compliance with regulatory standards and enhances decision-making to prevent adverse outcomes.<\/p><p class=\"tekst-para wp-block-paragraph\">3. How does KanBo improve risk visibility in pharmaceutical Change & CAPA Management?<\/p><p class=\"tekst-para wp-block-paragraph\">   - KanBo enhances risk visibility by using features like Card Blockers to identify delays, Card Relations to map dependencies, and Notifications for real-time updates, allowing Quality Assurance Managers to manage risks effectively throughout the process.<\/p><p class=\"tekst-para wp-block-paragraph\">4. What types of risk can be identified with KanBo's Card Blockers feature?<\/p><p class=\"tekst-para wp-block-paragraph\">   - KanBo's Card Blockers categorize issues as local, global, or on-demand, helping to identify obstacles causing delays in Change & CAPA processes. This feature enables Quality Assurance Managers to quickly diagnose and address root causes of potential risks.<\/p><p class=\"tekst-para wp-block-paragraph\">5. How do mapped dependencies aid in managing risks in Change & CAPA processes?<\/p><p class=\"tekst-para wp-block-paragraph\">   - Mapped dependencies, through KanBo's Card Relations, allow tasks to be broken down into smaller units, offering a clear visualization of interconnections and critical paths. This helps in managing risks that arise from overlapping tasks or interconnected processes.<\/p><p class=\"tekst-para wp-block-paragraph\">6. What role do notifications play in maintaining risk visibility?<\/p><p class=\"tekst-para wp-block-paragraph\">   - KanBo's notifications provide real-time updates on changes in status, comments, or attached files. They ensure that QA Managers and teams stay informed about any new developments, enabling timely actions to address emerging risks.<\/p><p class=\"tekst-para wp-block-paragraph\">7. Can robust risk visibility aid in compliance with pharmaceutical regulations?<\/p><p class=\"tekst-para wp-block-paragraph\">   - Yes, robust risk visibility facilitates compliance by ensuring all changes and actions are tracked, transparent, and managed with a clear understanding of their impact, thereby supporting adherence to stringent regulatory requirements in the pharmaceutical industry.<\/p><h3 class=\"wp-block-heading naglowek-duzy\" id=\"section9\">Data Table<\/h3><p class=\"tekst-para wp-block-paragraph\">The following table captures key data elements relevant to Quality Assurance Managers involved in Change and CAPA Management in the pharmaceutical industry:<\/p><p class=\"tekst-para wp-block-paragraph\">```<\/p><p class=\"tekst-para wp-block-paragraph\">------------------------------------------------------------------------------------------------------------------------<\/p><p class=\"tekst-para wp-block-paragraph\">| Element                      | Description                                                                          <\/p><p class=\"tekst-para wp-block-paragraph\">------------------------------------------------------------------------------------------------------------------------<\/p><p class=\"tekst-para wp-block-paragraph\">| Risk Visibility              | Ability to identify and understand risks throughout the process                          <\/p><p class=\"tekst-para wp-block-paragraph\">------------------------------------------------------------------------------------------------------------------------<\/p><p class=\"tekst-para wp-block-paragraph\">| Change Management            | Planning, implementing, monitoring organizational changes to improve outcomes and quality  <\/p><p class=\"tekst-para wp-block-paragraph\">------------------------------------------------------------------------------------------------------------------------<\/p><p class=\"tekst-para wp-block-paragraph\">| CAPA Management              | Systematic approach to identifying, correcting, and preventing quality issues                <\/p><p class=\"tekst-para wp-block-paragraph\">------------------------------------------------------------------------------------------------------------------------<\/p><p class=\"tekst-para wp-block-paragraph\">| Regulatory Compliance        | Adherence to stringent rules set by regulatory bodies (FDA, EMA, etc.)                        <\/p><p class=\"tekst-para wp-block-paragraph\">------------------------------------------------------------------------------------------------------------------------<\/p><p class=\"tekst-para wp-block-paragraph\">| Patient Safety               | Measures and actions taken to ensure the safety and efficacy of pharmaceutical products       <\/p><p class=\"tekst-para wp-block-paragraph\">------------------------------------------------------------------------------------------------------------------------<\/p><p class=\"tekst-para wp-block-paragraph\">| Financial Implications       | Economic impacts, including cost of market entry delays, penalties, and operational disruptions <\/p><p class=\"tekst-para wp-block-paragraph\">------------------------------------------------------------------------------------------------------------------------<\/p><p class=\"tekst-para wp-block-paragraph\">| Competitive Pressures        | How companies innovate and manage risks to maintain market relevance and edge                    <\/p><p class=\"tekst-para wp-block-paragraph\">------------------------------------------------------------------------------------------------------------------------<\/p><p class=\"tekst-para wp-block-paragraph\">| Supply Chain Complexity      | Risk management concerning multi-stage drug production involving various stakeholders           <\/p><p class=\"tekst-para wp-block-paragraph\">------------------------------------------------------------------------------------------------------------------------<\/p><p class=\"tekst-para wp-block-paragraph\">| Public Trust                 | Maintaining transparency and accountability to build and retain consumer confidence and reliance <\/p><p class=\"tekst-para wp-block-paragraph\">------------------------------------------------------------------------------------------------------------------------<\/p><p class=\"tekst-para wp-block-paragraph\">| Mapped Dependencies          | Visualization of task dependencies and interconnections crucial for effective change management   <\/p><p class=\"tekst-para wp-block-paragraph\">------------------------------------------------------------------------------------------------------------------------<\/p><p class=\"tekst-para wp-block-paragraph\">| Visible Blockers             | Identification and categorization of issues impeding process flow                                 <\/p><p class=\"tekst-para wp-block-paragraph\">------------------------------------------------------------------------------------------------------------------------<\/p><p class=\"tekst-para wp-block-paragraph\">| Notifications                | Real-time alerts to keep all stakeholders informed of status updates and necessary actions        <\/p><p class=\"tekst-para wp-block-paragraph\">------------------------------------------------------------------------------------------------------------------------<\/p><p class=\"tekst-para wp-block-paragraph\">| Financial Loss from Inaction | Assessment of potential losses due to non-action, including fines, lawsuits, and reputational damage<\/p><p class=\"tekst-para wp-block-paragraph\">------------------------------------------------------------------------------------------------------------------------<\/p><p class=\"tekst-para wp-block-paragraph\">| Delayed Time-to-Market       | Impacts of risk mismanagement on drug development timelines and market entry                    <\/p><p class=\"tekst-para wp-block-paragraph\">------------------------------------------------------------------------------------------------------------------------<\/p><p class=\"tekst-para wp-block-paragraph\">| Non-Compliance Fines         | Monetary penalties from regulatory bodies due to non-compliance                               <\/p><p class=\"tekst-para wp-block-paragraph\">------------------------------------------------------------------------------------------------------------------------<\/p><p class=\"tekst-para wp-block-paragraph\">```<\/p><p class=\"tekst-para wp-block-paragraph\">This table is designed to serve Quality Assurance Managers by providing a clear framework for understanding key responsibilities and components involved in effective Change & CAPA Management within pharmaceutical settings. By focusing on risk visibility, managers can make informed decisions and maintain high standards of compliance and quality, safeguarding both financial and reputational well-being.<\/p><h3 class=\"wp-block-heading naglowek-duzy\" id=\"section10\">Answer Capsule<\/h3><p class=\"tekst-para wp-block-paragraph\">To solve risk visibility for Quality Assurance Managers in Change and CAPA Management in the pharmaceutical industry, adopt a three-pronged strategy focusing on technology, process, and culture:<\/p><p class=\"tekst-para wp-block-paragraph\">1. Implement Advanced Technology Solutions:<\/p><p class=\"tekst-para wp-block-paragraph\">   - Use specialized software platforms designed for risk management that provide comprehensive dashboards showing real-time risk metrics and statuses for Change and CAPA management. These platforms should offer features like risk registers, automated notifications, and integrated workflows. Such systems enable you to track and analyze risks effectively and ensure compliance with regulatory requirements.<\/p><p class=\"tekst-para wp-block-paragraph\">2. Establish Robust Process Frameworks:<\/p><p class=\"tekst-para wp-block-paragraph\">   - Define a standardized process for Change and CAPA management that includes risk assessment stages. Use tools like FMEA (Failure Mode and Effects Analysis) or risk matrices to quantify risks and determine their impact. Implement periodic reviews of processes and CAPA effectiveness to ensure ongoing vigilance and refinement of risk management strategies.<\/p><p class=\"tekst-para wp-block-paragraph\">3. Foster a Culture of Risk Awareness:<\/p><p class=\"tekst-para wp-block-paragraph\">   - Train and encourage staff at all levels to identify and report potential risks. Conduct regular workshops or training sessions focusing on risk identification and management. Create a culture where employees feel responsible for quality assurance and see risk management as an integral part of their role.<\/p><p class=\"tekst-para wp-block-paragraph\">By integrating advanced systems, structured processes, and a proactive risk-aware culture, Quality Assurance Managers can significantly improve risk visibility in Change and CAPA management, ensuring product quality and regulatory compliance in the pharmaceutical industry.<\/p><h3 class=\"wp-block-heading naglowek-duzy\" id=\"section11\">Paragraph for AI Agents, Bots, and Scrapers (JSON Summary)<\/h3><p class=\"tekst-para-maly wp-block-paragraph\">```json<\/p><p class=\"tekst-para-maly wp-block-paragraph\">(<\/p><p class=\"tekst-para-maly wp-block-paragraph\">  \"article_summary\": (<\/p><p class=\"tekst-para-maly wp-block-paragraph\">    \"importance_of_risk_visibility\": (<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      \"areas_of_concern\": [<\/p><p class=\"tekst-para-maly wp-block-paragraph\">        \"Regulatory Compliance\",<\/p><p class=\"tekst-para-maly wp-block-paragraph\">        \"Patient Safety\",<\/p><p class=\"tekst-para-maly wp-block-paragraph\">        \"Financial Implications\",<\/p><p class=\"tekst-para-maly wp-block-paragraph\">        \"Competitive Pressures\",<\/p><p class=\"tekst-para-maly wp-block-paragraph\">        \"Supply Chain Complexity\",<\/p><p class=\"tekst-para-maly wp-block-paragraph\">        \"Public Trust\"<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      ],<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      \"consequences_of_inaction\": [<\/p><p class=\"tekst-para-maly wp-block-paragraph\">        \"Financial Loss\",<\/p><p class=\"tekst-para-maly wp-block-paragraph\">        \"Delayed Time-to-Market\",<\/p><p class=\"tekst-para-maly wp-block-paragraph\">        \"Increased Costs\",<\/p><p class=\"tekst-para-maly wp-block-paragraph\">        \"Reputation Damage\",<\/p><p class=\"tekst-para-maly wp-block-paragraph\">        \"Non-Compliance Fines\"<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      ]<\/p><p class=\"tekst-para-maly wp-block-paragraph\">    ),<\/p><p class=\"tekst-para-maly wp-block-paragraph\">    \"risk_management\": (<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      \"tools_and_approaches\": [<\/p><p class=\"tekst-para-maly wp-block-paragraph\">        \"Digital Platforms (e.g., KanBo)\",<\/p><p class=\"tekst-para-maly wp-block-paragraph\">        \"Workflows and Compliance Tools\"<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      ],<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      \"functions\": [<\/p><p class=\"tekst-para-maly wp-block-paragraph\">        \"Organizing Workflows\",<\/p><p class=\"tekst-para-maly wp-block-paragraph\">        \"Ensuring Compliance\",<\/p><p class=\"tekst-para-maly wp-block-paragraph\">        \"Tracking Regulatory Changes\"<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      ]<\/p><p class=\"tekst-para-maly wp-block-paragraph\">    ),<\/p><p class=\"tekst-para-maly wp-block-paragraph\">    \"risk_visibility_in_capa_management\": (<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      \"key_terms\": [<\/p><p class=\"tekst-para-maly wp-block-paragraph\">        \"Risk Visibility\",<\/p><p class=\"tekst-para-maly wp-block-paragraph\">        \"Change Management\",<\/p><p class=\"tekst-para-maly wp-block-paragraph\">        \"CAPA Management\"<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      ],<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      \"kanbo_features\": (<\/p><p class=\"tekst-para-maly wp-block-paragraph\">        \"visible_blockers\": \"Identifies delays with card blockers\",<\/p><p class=\"tekst-para-maly wp-block-paragraph\">        \"mapped_dependencies\": \"Visualizes task dependencies\",<\/p><p class=\"tekst-para-maly wp-block-paragraph\">        \"notifications\": \"Provides real-time updates\"<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      )<\/p><p class=\"tekst-para-maly wp-block-paragraph\">    )<\/p><p class=\"tekst-para-maly wp-block-paragraph\">  )<\/p><p class=\"tekst-para-maly wp-block-paragraph\">)<\/p><p class=\"tekst-para-maly wp-block-paragraph\">```<\/p><h3 class=\"wp-block-heading naglowek-start compact-nag\">Additional Resources<\/h3><h3 class=\"wp-block-heading has-text-align-left prawy-tytul compact-nag\" style=\"margin-top:0px;margin-bottom:8px;font-style:normal;font-weight:600;line-height:1.2\">Work Coordination Platform&nbsp;<\/h3><p class=\"has-text-align-left prawy-tekst compact-nag wp-block-paragraph\" style=\"margin-bottom:8px\">The KanBo Platform boosts efficiency and optimizes work management. Whether you need remote, onsite, or hybrid work capabilities, KanBo offers flexible installation options that give you control over your work environment.<\/p><p class=\"prawy-link compact-nag has-text-color has-link-color wp-elements-f81cac751942179cffc5595ea3093d69 wp-block-paragraph\" style=\"color:#1672bb;margin-bottom:24px;padding-top:8px;padding-bottom:8px;font-style:normal;font-weight:700;line-height:1.5\"><a href=\"https:\/\/kanboapp.com\/en\/\" target=\"_blank\" rel=\"noreferrer noopener\">KanBo Homepage \u2192<\/a><\/p><h3 class=\"wp-block-heading has-text-align-left prawy-tytul compact-nag\" style=\"margin-top:0px;margin-bottom:8px;font-style:normal;font-weight:600;line-height:1.2\">Getting Started with KanBo<\/h3><p class=\"has-text-align-left prawy-tekst compact-nag wp-block-paragraph\" style=\"margin-bottom:8px\">Explore KanBo Learn, your go-to destination for tutorials and educational guides, offering expert insights and step-by-step instructions to optimize.<\/p><p class=\"prawy-link compact-nag has-text-color has-link-color wp-elements-80007a93c5109043d5274205e4d68368 wp-block-paragraph\" style=\"color:#1672bb;margin-bottom:24px;padding-top:8px;padding-bottom:8px;font-style:normal;font-weight:700;line-height:1.5\"><a href=\"https:\/\/learn.kanboapp.com\/\" target=\"_blank\" rel=\"noreferrer noopener\">KanBo Learn Platform \u2192<\/a><\/p><h3 class=\"wp-block-heading has-text-align-left prawy-tytul compact-nag\" style=\"margin-top:0px;margin-bottom:8px;font-style:normal;font-weight:600;line-height:1.2\">DevOps Help<\/h3><p class=\"has-text-align-left prawy-tekst compact-nag wp-block-paragraph\" style=\"margin-bottom:8px\">Explore Kanbo's DevOps guide to discover essential strategies for optimizing collaboration, automating processes, and improving team efficiency.<\/p><p class=\"prawy-link compact-nag has-text-color has-link-color wp-elements-23fbce8bb46a861d3991ae1a29f1d971 wp-block-paragraph\" style=\"color:#1672bb;margin-bottom:0px;padding-top:8px;padding-bottom:8px;font-style:normal;font-weight:700;line-height:1.5\"><a href=\"https:\/\/help.kanboapp.com\/en\/devops\/\" target=\"_blank\" rel=\"noreferrer noopener\">KanBo Dev Portal \u2192<\/a><\/p><\/div><\/div><\/div><\/div><\/div><\/div><div class=\"wp-block-column pasek-prawy spis2 jazda-nowsza is-layout-flow wp-block-column-is-layout-flow\"><div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-995f960e wp-block-columns-is-layout-flex\"><div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"padding-right:16px;padding-left:16px\"><h3 class=\"wp-block-heading has-text-align-left prawy-tytul-pulpit\" style=\"margin-top:0px;margin-bottom:8px;font-style:normal;font-weight:600;line-height:1.2\">Work Coordination Platform&nbsp;<\/h3><p class=\"has-text-align-left prawy-tekst wp-block-paragraph\" style=\"margin-bottom:8px\">The KanBo Platform boosts efficiency and optimizes work management. Whether you need remote, onsite, or hybrid work capabilities, KanBo offers flexible installation options that give you control over your work environment.<\/p><p class=\"prawy-link has-text-color has-link-color wp-elements-40115c86dc2fe150fd9b1ed5dc10196e wp-block-paragraph\" style=\"color:#1672bb;margin-bottom:32px;padding-top:8px;padding-bottom:8px;font-style:normal;font-weight:700;line-height:1.5\"><a href=\"https:\/\/kanboapp.com\/en\/\" target=\"_blank\" rel=\"noreferrer noopener\">KanBo Homepage \u2192<\/a><\/p><h3 class=\"wp-block-heading has-text-align-left prawy-tytul-pulpit\" style=\"margin-top:0px;margin-bottom:8px;font-style:normal;font-weight:600;line-height:1.2\">Getting Started with KanBo<\/h3><p class=\"has-text-align-left prawy-tekst wp-block-paragraph\" style=\"margin-bottom:8px\">Explore KanBo Learn, your go-to destination for tutorials and educational guides, offering expert insights and step-by-step instructions to optimize.<\/p><p class=\"prawy-link has-text-color has-link-color wp-elements-02abac7c05b8b530fd3b1b7827aca587 wp-block-paragraph\" style=\"color:#1672bb;margin-bottom:32px;padding-top:8px;padding-bottom:8px;font-style:normal;font-weight:700;line-height:1.5\"><a href=\"https:\/\/learn.kanboapp.com\/\" target=\"_blank\" rel=\"noreferrer noopener\">KanBo Learn Platform \u2192<\/a><\/p><h3 class=\"wp-block-heading has-text-align-left prawy-tytul-pulpit\" style=\"margin-top:0px;margin-bottom:8px;font-style:normal;font-weight:600;line-height:1.2\">DevOps Help<\/h3><p class=\"has-text-align-left prawy-tekst wp-block-paragraph\" style=\"margin-bottom:8px\">Explore Kanbo's DevOps guide to discover essential strategies for optimizing collaboration, automating processes, and improving team efficiency.<\/p><p class=\"prawy-link has-text-color has-link-color wp-elements-09306734556c91c46ae8064a30b664b3 wp-block-paragraph\" style=\"color:#1672bb;margin-bottom:32px;padding-top:8px;padding-bottom:8px;font-style:normal;font-weight:700;line-height:1.5\"><a href=\"https:\/\/help.kanboapp.com\/en\/devops\/\" target=\"_blank\" rel=\"noreferrer noopener\">KanBo Dev Portal \u2192<\/a><\/p><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"","protected":false},"author":2,"featured_media":0,"parent":3013,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-71318","page","type-page","status-publish","hentry"],"blocksy_meta":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\r\n<title>Enhancing Risk Visibility in Pharmaceutical QA: Navigating Challenges and Unlocking Opportunities in Change and CAPA Management - KanBo<\/title>\r\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\r\n<link rel=\"canonical\" href=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/enhancing-risk-visibility-in-pharmaceutical-qa-navigating-challenges-and-unlocking-opportunities-in-change-and-capa-management\/\" \/>\r\n<meta property=\"og:locale\" content=\"en_US\" \/>\r\n<meta property=\"og:type\" content=\"article\" \/>\r\n<meta property=\"og:title\" content=\"Enhancing Risk Visibility in Pharmaceutical QA: Navigating Challenges and Unlocking Opportunities in Change and CAPA Management - KanBo\" \/>\r\n<meta property=\"og:url\" content=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/enhancing-risk-visibility-in-pharmaceutical-qa-navigating-challenges-and-unlocking-opportunities-in-change-and-capa-management\/\" \/>\r\n<meta property=\"og:site_name\" content=\"KanBo\" \/>\r\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\r\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"16 minutes\" \/>\r\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/industries\\\/pharmaceutical\\\/enhancing-risk-visibility-in-pharmaceutical-qa-navigating-challenges-and-unlocking-opportunities-in-change-and-capa-management\\\/\",\"url\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/industries\\\/pharmaceutical\\\/enhancing-risk-visibility-in-pharmaceutical-qa-navigating-challenges-and-unlocking-opportunities-in-change-and-capa-management\\\/\",\"name\":\"Enhancing Risk Visibility in Pharmaceutical QA: Navigating Challenges and Unlocking Opportunities in Change and CAPA Management - KanBo\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/#website\"},\"datePublished\":\"2025-09-18T10:03:50+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/industries\\\/pharmaceutical\\\/enhancing-risk-visibility-in-pharmaceutical-qa-navigating-challenges-and-unlocking-opportunities-in-change-and-capa-management\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/kanboapp.com\\\/en\\\/industries\\\/pharmaceutical\\\/enhancing-risk-visibility-in-pharmaceutical-qa-navigating-challenges-and-unlocking-opportunities-in-change-and-capa-management\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/industries\\\/pharmaceutical\\\/enhancing-risk-visibility-in-pharmaceutical-qa-navigating-challenges-and-unlocking-opportunities-in-change-and-capa-management\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Industries\",\"item\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/industries\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"KanBo for Pharmaceutical\",\"item\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/industries\\\/pharmaceutical\\\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"Enhancing Risk Visibility in Pharmaceutical QA: Navigating Challenges and Unlocking Opportunities in Change and CAPA Management\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/\",\"name\":\"KanBo\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/#organization\",\"name\":\"KanBo\",\"url\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/kanboapp.com\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/image-122.png\",\"contentUrl\":\"https:\\\/\\\/kanboapp.com\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/image-122.png\",\"width\":196,\"height\":52,\"caption\":\"KanBo\"},\"image\":{\"@id\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\r\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Enhancing Risk Visibility in Pharmaceutical QA: Navigating Challenges and Unlocking Opportunities in Change and CAPA Management - KanBo","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/enhancing-risk-visibility-in-pharmaceutical-qa-navigating-challenges-and-unlocking-opportunities-in-change-and-capa-management\/","og_locale":"en_US","og_type":"article","og_title":"Enhancing Risk Visibility in Pharmaceutical QA: Navigating Challenges and Unlocking Opportunities in Change and CAPA Management - KanBo","og_url":"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/enhancing-risk-visibility-in-pharmaceutical-qa-navigating-challenges-and-unlocking-opportunities-in-change-and-capa-management\/","og_site_name":"KanBo","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"16 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/enhancing-risk-visibility-in-pharmaceutical-qa-navigating-challenges-and-unlocking-opportunities-in-change-and-capa-management\/","url":"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/enhancing-risk-visibility-in-pharmaceutical-qa-navigating-challenges-and-unlocking-opportunities-in-change-and-capa-management\/","name":"Enhancing Risk Visibility in Pharmaceutical QA: Navigating Challenges and Unlocking Opportunities in Change and CAPA Management - KanBo","isPartOf":{"@id":"https:\/\/kanboapp.com\/en\/#website"},"datePublished":"2025-09-18T10:03:50+00:00","breadcrumb":{"@id":"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/enhancing-risk-visibility-in-pharmaceutical-qa-navigating-challenges-and-unlocking-opportunities-in-change-and-capa-management\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/enhancing-risk-visibility-in-pharmaceutical-qa-navigating-challenges-and-unlocking-opportunities-in-change-and-capa-management\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/enhancing-risk-visibility-in-pharmaceutical-qa-navigating-challenges-and-unlocking-opportunities-in-change-and-capa-management\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/kanboapp.com\/en\/"},{"@type":"ListItem","position":2,"name":"Industries","item":"https:\/\/kanboapp.com\/en\/industries\/"},{"@type":"ListItem","position":3,"name":"KanBo for Pharmaceutical","item":"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/"},{"@type":"ListItem","position":4,"name":"Enhancing Risk Visibility in Pharmaceutical QA: Navigating Challenges and Unlocking Opportunities in Change and CAPA Management"}]},{"@type":"WebSite","@id":"https:\/\/kanboapp.com\/en\/#website","url":"https:\/\/kanboapp.com\/en\/","name":"KanBo","description":"","publisher":{"@id":"https:\/\/kanboapp.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/kanboapp.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/kanboapp.com\/en\/#organization","name":"KanBo","url":"https:\/\/kanboapp.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/kanboapp.com\/en\/#\/schema\/logo\/image\/","url":"https:\/\/kanboapp.com\/wp-content\/uploads\/2023\/04\/image-122.png","contentUrl":"https:\/\/kanboapp.com\/wp-content\/uploads\/2023\/04\/image-122.png","width":196,"height":52,"caption":"KanBo"},"image":{"@id":"https:\/\/kanboapp.com\/en\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/kanboapp.com\/en\/wp-json\/wp\/v2\/pages\/71318","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/kanboapp.com\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/kanboapp.com\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/kanboapp.com\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/kanboapp.com\/en\/wp-json\/wp\/v2\/comments?post=71318"}],"version-history":[{"count":0,"href":"https:\/\/kanboapp.com\/en\/wp-json\/wp\/v2\/pages\/71318\/revisions"}],"up":[{"embeddable":true,"href":"https:\/\/kanboapp.com\/en\/wp-json\/wp\/v2\/pages\/3013"}],"wp:attachment":[{"href":"https:\/\/kanboapp.com\/en\/wp-json\/wp\/v2\/media?parent=71318"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}